Tanaka, Keisuke
Kikuchi, Hiroaki
Umezawa, Yoshihiro
Mori, Takehiko
Fushimi, Kiyohide
Yamamoto, Masahide https://orcid.org/0000-0002-3142-8806
Article History
Received: 13 April 2025
Revised: 22 July 2025
Accepted: 22 July 2025
First Online: 6 August 2025
Declarations
:
: Keisuke Tanaka reports honoraria from Novartis. Yoshihiro Umezawa reports honoraria from Novartis. Takehiko Mori reports honoraria from Novartis, Daiichi Sankyo, Bristol-Myers Squibb. Masahide Yamamoto reports honoraria from Novartis, Bristol-Myers Squibb.
: Informed consent were waived because this was retrospective study using the databese of Japanese medical and health service and there was a minimal risk to participants.